Patrick Frost, PhD

Patrick Frost, PhD

Jan 15, 2016

Group 6 Copy 49
2
Please wait...

About This Project

BBRI and Los Angeles VA Medical Center

Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.

Blast off!

Browse Other Projects on Experiment

Related Projects

Biological Diversity on a Northeast Ohio College Campus

"Biodiversity" describes how many and what kind of organisms live in a place. It is an important measure...

Climate change threats to the American pika

This project will collect critical data for assessing how climate change will impact the American pika.

Backer Badge Funded